Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-18

Clinical Trial Update: Oxytocin and Social Cognition in Frontotemporal Dementia [NA]

View source ↗

Summary

A completed clinical trial evaluating oxytocin and social cognition in people with Frontotemporal dementia (including Pick's disease).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Frontotemporal Dementia, Pick's Disease | NA | Status: COMPLETED